Methods of treating mental retardation, Down's syndrome, fragile X syndrome and autism

Details for Australian Patent Application No. 2007325836 (hide)

Owner SeaSide Therapeutics, Inc.

Inventors Roberts, Kathryn; Carpenter, Randall L.; Bear, Mark F.

Agent Pizzeys

Pub. Number AU-B-2007325836

PCT Pub. Number WO2008/066750

Priority 61/001,567 02.11.07 US; 60/860,733 22.11.06 US

Filing date 21 November 2007

Wipo publication date 5 June 2008

Acceptance publication date 21 July 2011

International Classifications

A61K 31/195 (2006.01)

A61K 31/215 (2006.01)

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

11 June 2009 PCT application entered the National Phase

  PCT publication WO2008/066750 Priority application(s): WO2008/066750

15 April 2010 Alteration of Name

  The name of the applicant has been altered to SeaSide Therapeutics, Inc.

21 July 2011 Application Accepted

  Published as AU-B-2007325836

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007325838-Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

2007325829-Disposable infusion device filling apparatus and method